Almirall D, Compton SN, Gunlicks-Stoessel M, Duan N, Murphy SA (2012) Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy. Stat Med 31:1887–1902. https://doi.org/10.1002/sim.4512
Article PubMed PubMed Central Google Scholar
Chen Z, Marple K, Salazar E, Gupta G, Tamil L (2016) A physician advisory system for chronic heart failure management based on knowledge patterns. Theory Pract Logic Program 16:604–618. https://doi.org/10.1017/S1471068416000429
Hannes K et al (2005) Implementing evidence-based medicine in general practice: a focus group based study. BMC Family Pract. https://doi.org/10.1186/1471-2296-6-37
Garcia-Abeijon P et al (2023) Factors associated with underreporting of adverse drug reactions by health care professionals: a systematic review update. Drug Safety 46:625–636. https://doi.org/10.1007/s40264-023-01302-7
Article PubMed PubMed Central Google Scholar
Montane E, Castells X (2021) Epidemiology of drug-related deaths in european hospitals: a systematic review and meta-analysis of observational studies. Br J Clin Pharmacol 87:3659–3671
Article CAS PubMed Google Scholar
Maxfield K, Zineh I (2021) Precision dosing: a clinical and public health imperative. JAMA 325:1505. https://doi.org/10.1001/jama.2021.1004
Peck RW (2020) Precision dosing: an industry perspective. Clin Pharmacol Ther 109:47–50. https://doi.org/10.1002/cpt.2064
Article PubMed PubMed Central Google Scholar
Sheiner LB (1969) Computer-aided long-term anticoagulation therapy. Comput Biomed Res 2:507–518. https://doi.org/10.1016/0010-4809(69)90030-5
Article CAS PubMed Google Scholar
Jelliffe RW (1969) Administration of digoxin. Dis Chest 56:56–60. https://doi.org/10.1378/chest.56.1.56
Article CAS PubMed Google Scholar
Wright DF, Martin JH, Cremers S (2019) Spotlight commentary: Modelinformed precision dosing must demonstrate improved patient outcomes. Br J Clin Pharmacol 85:2238–2240. https://doi.org/10.1111/bcp.14050
Article PubMed PubMed Central Google Scholar
Polasek TM et al (2018) Toward dynamic prescribing information: Codevelopment of companion model-informed precision dosing tools in drug development. Clin Pharmacol Drug Develop 8:418–425. https://doi.org/10.1002/cpdd.638
Peters SA (2008) Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis. Clin Pharmacokinet 47:261–275. https://doi.org/10.2165/00003088-200847040-00004
Article CAS PubMed Google Scholar
Willmann S et al (2007) Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs. J Pharmacokinet Pharmacodyn 34:401–431. https://doi.org/10.1007/s10928-007-9053-5
Lippert J et al (2012) A mechanistic, model-based approach to safety assessment in clinical development. CPT: Pharmacomet Syst Pharmacol 1:1–8. https://doi.org/10.1038/psp.2012.14
Ribba B, Bram DS, Baverel PG, Peck RW (2022) Model enhanced reinforcement learning to enable precision dosing: a theoretical case study with dosing of propofol. CPT: Pharmacomet Syst Pharmacol 11:1497–1510. https://doi.org/10.1002/psp4.12858
Visentin R, Cobelli C, Dalla Man C (2020) The padova type 2 diabetes simulator from triple-tracer single-meal studies: In silico trials also possible in rare but not-so-rare individuals. Diabet Technol Ther 22:892–903. https://doi.org/10.1089/dia.2020.0110
Levy G (1977) Pharmacokinetics in renal disease. Am J Med 62:461–465. https://doi.org/10.1016/0002-9343(77)90397-7
Article CAS PubMed Google Scholar
Reinisch V, Paudel A, Pinto JT (2023) Development of a digital interface for personalized dosing in renal impaired patients: a case-study using the ACE-inhibitor benazepril. IOS Press, Amsterdam. https://doi.org/10.3233/SHTI230027
Balfour JA, Goa KL (1991) Benazepril: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure. Drugs 42:511–539. https://doi.org/10.2165/00003495-199142030-00008
Article CAS PubMed Google Scholar
Sheiner LB, Beal S, Rosenberg B, Marathe VV (1979) Forecasting individual pharmacokinetics. Clin Pharmacol Ther 26:294–305. https://doi.org/10.1002/cpt1979263294
Article CAS PubMed Google Scholar
Duffull SB, Begg EJ, Robinson BA, Deely JJ (1997) A sequential bayesian algorithm for dose individualisation of carboplatin. Cancer Chemother Pharmacol 39:317–326. https://doi.org/10.1007/s002800050578
Article CAS PubMed Google Scholar
Lu J, Deng K, Zhang X, Liu G, Guan Y (2021) Neural-ode for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens. iScience 24:102804. https://doi.org/10.1016/j.isci.2021.102804
Article CAS PubMed PubMed Central Google Scholar
Yu C, Liu J, Zhao H (2019) Inverse reinforcement learning for intelligent mechanical ventilation and sedative dosing in intensive care units. BMC Med Inform Decis Mak. https://doi.org/10.1186/s12911-019-0763-6
Article PubMed PubMed Central Google Scholar
Ghassemi M, Alhanai T, Westover M, Mark T, Nemati S (2018) Personalized medication dosing using volatile data streams, AAAI’18. New Orleans, Louisiana. https://aaai.org/ocs/index.php/WS/AAAIW18/paper/view/17234
Lin R, Stanley MD, Ghassemi MM, Nemati S (2018) A deep deterministic policy gradient approach to medication dosing and surveillance in the icu. IEEE. https://doi.org/10.1109/EMBC.2018.8513203
Padmanabhan R, Meskin N, Haddad WM (2019) Optimal adaptive control of drug dosing using integral reinforcement learning. Math Biosci 309:131–142. https://doi.org/10.1016/j.mbs.2019.01.012
Borera EC, Moore BL, Doufas AG, Pyeatt LD (2011) An adaptive neural network filter for improved patient state estimation in closed-loop anesthesia control. IEEE. https://doi.org/10.1109/ictai.2011.15
Padmanabhan R, Meskin N, Haddad WM (2014) Closed-loop control of anesthesia and mean arterial pressure using reinforcement learning. IEEE. https://doi.org/10.1109/ADPRL.2014.7010644
Padmanabhan R, Meskin N, Haddad WM (2017) Reinforcement learning-based control for combined infusion of sedatives and analgesics. IEEE. https://doi.org/10.1109/codit.2017.8102643
Raghu A, Komorowski M, Celi LA, Szolovits P, Ghassemi M, DoshiVelez F et al (eds) (2017) Continuous state-space models for optimal sepsis treatment: a deep reinforcement learning approach. (eds Doshi-Velez, F. et al) Proceedings of the 2nd machine learning for healthcare conference, Vol. 68 of Proceedings of machine learning research, 147–163. PMLR. https://proceedings.mlr.press/v68/raghu17a.html
Sun L, von Moltke L, Rowland Yeo K (2020) Application of physiologically based pharmacokinetic modeling to predict the effect of renal impairment on the pharmacokinetics of olanzapine and samidorphan given in combination. Clin Pharmacokinet 60:637–647. https://doi.org/10.1007/s40262-020-00969-w
Article CAS PubMed PubMed Central Google Scholar
Li L-P et al (2017) Evaluation of renal blood flow in chronic kidney disease using arterial spin labeling perfusion magnetic resonance imaging. Kidney Int Rep 2:36–43. https://doi.org/10.1016/j.ekir.2016.09.003
Schaefer AJ, Bailey MD, Shechter SM, Roberts MS (2005) Modeling medical treatment using markov decision processes. Springer, US, pp 593–612
Sutton RS, Barto AG (2018) Reinforcement learning: an introduction. MIT press, Cambridge
Watkins CJCH (1989) Learning from delayed rewards
van Hasselt H (2012) Reinforcement learning in continuous state and action spaces. Springer, Berlin Heidelberg, pp 207–251
Mitchell T (1997) Machine Learning McGraw-Hill series in computer science. McGrawHill Professional, New York
Gorostidi M et al (2014) Spanish society of nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease. Nefrologia 34:302–316
Organization WH et al (2005) Surveillance of chronic disease risk factors: country level data and comparable estimates
Comments (0)